Stem Cell Models for Cancer Therapy

Int J Mol Sci. 2022 Jun 24;23(13):7055. doi: 10.3390/ijms23137055.

Abstract

Metastatic progression of female breast and colon cancer represents a major cause of mortality in women. Spontaneous/acquired resistance to conventional and targeted chemo-endocrine therapy is associated with the emergence of drug-resistant tumor-initiating cancer stem cell populations. The cancer-initiating premalignant stem cells exhibit activation of select cancer cell signaling pathways and undergo epithelial-mesenchymal transition, leading to the evolution of a metastatic phenotype. The development of reliable cancer stem cell models provides valuable experimental approaches to identify novel testable therapeutic alternatives for therapy-resistant cancer. Drug-resistant stem cell models for molecular subtypes of clinical breast cancer and for genetically predisposed colon cancer are developed by selecting epithelial cells that survive in the presence of cytostatic concentrations of relevant therapeutic agents. These putative stem cells are characterized by the expression status of select cellular and molecular stem cell markers. The stem cell models are utilized as experimental approaches to examine the stem-cell-targeted growth inhibitory efficacy of naturally occurring dietary phytochemicals. The present review provides a systematic discussion on (i) conceptual and experimental aspects relevant to the chemo-endocrine therapy of breast and colon cancer, (ii) molecular/cellular aspects of cancer stem cells and (iii) potential stem-cell-targeting lead compounds as testable alternatives against the progression of therapy-resistant breast and colon cancer.

Keywords: breast and colon cancer; stem cells; testable therapeutic alternatives.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms* / pathology
  • Cell Line, Tumor
  • Cell Proliferation
  • Colonic Neoplasms* / drug therapy
  • Colonic Neoplasms* / pathology
  • Epithelial-Mesenchymal Transition
  • Female
  • Humans
  • Neoplastic Stem Cells / metabolism

Grants and funding

This study received no external funding.